10-KPeriod: FY2018

MICROCHIP TECHNOLOGY INC Annual Report, Year Ended Mar 31, 2018

Filed May 18, 2018For Securities:MCHPMCHPP

Summary

This 10-K filing from Microchip Technology Inc. (MCHP) for the fiscal year ending March 31, 2018, highlights a significant upcoming event: the definitive agreement to acquire Microsemi Corporation for approximately $8.35 billion in cash. This acquisition is expected to close in late May/early June 2018 and is a major strategic move to expand Microchip's offerings in aerospace, defense, communications, data center, and industrial markets. The company's core business remains focused on developing and selling specialized semiconductor products for embedded control applications. Microchip continues to invest in new product development and manufacturing process technologies to maintain its competitive edge. The filing also details the company's sales performance, which saw an increase driven by favorable economic conditions and product volume growth, with Asia remaining the largest geographic market.

Financial Statements
Beta
Revenue$3.98B
Cost of Revenue$1.56B
Gross Profit$2.42B
R&D Expenses$529.30M
SG&A Expenses$452.10M
Operating Expenses$1.48B
Operating Income$936.30M
Interest Expense$199.00M
Net Income$255.40M
EPS (Basic)$0.55
EPS (Diluted)$0.52
Shares Outstanding (Basic)465.80M
Shares Outstanding (Diluted)497.80M

Key Highlights

  • 1Microchip Technology announced a definitive agreement to acquire Microsemi Corporation for approximately $8.35 billion, expected to close in late May/early June 2018.
  • 2Net sales increased by 16.8% to $3,980.8 million in fiscal 2018, driven by favorable economic and semiconductor industry conditions, alongside market share gains.
  • 3Microcontrollers remain the dominant product line, accounting for 65.9% of net sales in fiscal 2018.
  • 4Asia continues to be the largest market, contributing 57.8% of net sales in fiscal 2018.
  • 5The company generated strong operating cash flows of $1,419.6 million in fiscal 2018.
  • 6Long-lived assets were reported at $767.9 million as of March 31, 2018, with the United States accounting for the largest portion.
  • 7R&D expenses decreased slightly to $529.3 million in fiscal 2018, reflecting efficiency gains post-acquisition.

Frequently Asked Questions